Posted On: 08/15/2016 8:11:00 AM
Post# of 94164
$ARTH ~ Arch Therapeutics Reports AC5 Topical Hemostatic Device Meets Primary and Secondary Endpoints in First Clinical Study
http://finance.yahoo.com/news/arch-therapeuti...00951.html
http://finance.yahoo.com/news/arch-therapeuti...00951.html
(0)
(0)Scroll down for more posts ▼
